Core-005
Core-005
批准号:
10198074
负责人:
David H Ellison
金额:
$164.5万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-02 至 2022-08-30
关键词:
AddressAdoptedAreaCenter for Translational Science ActivitiesChild HealthClinicalClinical ResearchDevelopmentDiseaseEnsureEthicsEvaluationEvolutionFoundationsFundingGoalsGrowthHealthHumanImpairmentInterventionKnowledgeLaboratoriesLearning ModuleLongevityMentorsModelingOlder PopulationOregonParticipantPerformancePersonal SatisfactionPhenotypeProcessResearchResearch InstituteResearch PersonnelResource SharingRural PopulationSiteSpecial PopulationStructureStudentsTechniquesTherapeuticTranslational ResearchUniversitiescareer developmentearly phase clinical trialhuman diseaseimprovedinformatics toolpatient oriented researchprogramsresearch studyrural underservedstressorsymposium
中文摘要
OHSU在儿童健康、老年人口、终身疾病等方面拥有强大的研究组合,以及
服务不足的农村人口。然而,在对这些方面的协调支持方面存在着重大差距
损害这些努力的最佳性能和扩展的重要计划。新的OCTRI
整合特殊人口单位将加强儿童健康、老年人口、疾病等方面的研究
对当前需求、发展和未得到充分服务的农村人口进行关键分析
确定满足这些需求的可行目标,落实最高优先目标,以及评价和
传播最有效的进程。计划的活动包括区域会议和务虚会
与调查人员和其他利益攸关方合作,开发工具包和其他教育模块,加强
信息学工具,以及为每个程序量身定做的其他技术。互联网服务供应商将与
CTSA网络采用其他CTSA站点开发的有效技术,并分享当地经过验证的
经过仔细评估后的技术。这些努力将加强对这些地区与健康有关的问题的了解
改善干预措施,以优化他们的健康和福祉。
OCTRI临床和翻译研究中心(CTRC)极大地扩展和增强了
在OHSU进行临床研究,在过去五年中取得了前所未有的增长。反恐委员会还
作为OHSU临床研究职业发展的主要场所。然而,CTRC上的压力源
业务和财务结构需要新的筹资模式和更高的业务效率。
这些成就和挑战为八达通社参与者和
未来五年的临床交互(PCI)研究能力。CTRC将以科学的方式催化
严谨、合乎道德、可行和高效的以患者为中心的研究,重点是强化研究
OHSU研究人员在高优先领域的表型和早期临床试验。这些努力将
增进对多种人类疾病的认识,为疾病特异性治疗奠定基础
以增进人类健康。反恐委员会还将继续利用和加强OCTRI教育
通过利用CTRC作为学生、研究人员和研究人员的指导性“实验室”来计划
坚持以病人为中心的研究。最后,反恐委员会将完成向新的业务部门的过渡。
将模型作为大学共享资源(USR),结合持续质量改进以确保
建立了可持续和高效的业务和财务程序,以便以最佳方式支持公共部门改革
在俄亥俄州立大学和该地区进行研究。
英文摘要
OHSU has a robust research portfolio in child health, older populations, diseases across the lifespan, and
underserved rural populations. However, there are significant gaps in coordinated support for these
important programs that impair optimal performance and expansion of these efforts. The new OCTRI
Integrating Special Populations unit (ISP) will enhance research in child health, older populations, diseases
across the lifespan, and underserved rural populations with a critical analysis of current needs, development
of feasible goals to address these needs, implementation of the highest priority goals, and evaluation and
dissemination of the most effective processes. Planned activities include regional conferences and retreats
with investigators and other stakeholders, development of toolkits and other educational modules, enhanced
informatics tools, and other techniques tailored to each program. The ISP will coordinate closely with the
CTSA network to adopt effective techniques developed at other CTSA sites, and to share local proven
techniques after careful evaluation. These efforts will enhance knowledge of health-related issues in these
special populations, leading to improved interventions to optimize their health and well-being.
The OCTRI Clinical and Translational Research Center (CTRC) has greatly expanded and enhanced the
conduct of clinical research at OHSU, with unprecedented growth over the past five years. The CTRC also
serves as a major site for career development in clinical research at OHSU. However, stressors on CTRC
operational and financial structures require a new funding model and increased operational efficiencies.
These accomplishments and challenges set the stage for continued evolution of OCTRI’s Participant and
Clinical Interactions (PCI) research capacity for the next five years. The CTRC will catalyze scientifically
rigorous, ethical, feasible, and efficient patient-oriented research studies, with an emphasis on intensive
phenotyping and early phase clinical trials in high priority areas for OHSU investigators. These efforts will
advance knowledge of numerous human diseases and lay the foundations for disease-specific therapeutics
to enhance human health. The CTRC will also continue to leverage and enhance the OCTRI Educational
Program by utilizing the CTRC as the mentored “laboratory” for students, investigators, and study staff
pursuing patient- oriented research. Finally, the CTRC will complete its transition to a new operational
model as a University Shared Resource (USR), incorporating continuous quality improvement to ensure
that sustainable and efficient operational and financial processes are in place to optimally support PCI
research at OHSU and the region.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core-003
-
批准号:10198072
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Admin-Core-001
-
批准号:10198069
-
项目类别:
-
资助金额:$90.49万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project
-
批准号:10158949
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10198068
-
项目类别:
-
资助金额:$630.8万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10693308
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9514362
-
项目类别:
-
资助金额:$616.99万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
-
批准号:10179888
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-001
-
批准号:10198070
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-002
-
批准号:10198071
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - Evaluation of OCTRI's Response to COVID-19
-
批准号:10158990
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-007
-
批准号:10198076
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-006
-
批准号:10198075
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10675189
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-004
-
批准号:10198073
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9977301
-
项目类别:
-
资助金额:$633.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9816556
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Renal Effects of Aldosterone
-
批准号:10266000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:9280815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:8635009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Molecular pathogenesis of calcineurin inhibitor-induced hypertension
-
批准号:8549218
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2012
-
负责人:David H Ellison
-
依托单位:
海外基金